Long-Term Aminobisphosphonate Treatment of Fibrous Dysplasia: Spectacular Increase in Bone Density

Weinstein, 1991, Activating mutations of the stimulatory G protein in the McCune-Albright syndrome, N Engl J Med, 325, 1688, 10.1056/NEJM199112123252403

Shenker, 1994, An activating Gsα mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome, J Clin Endocrinol Metab, 79, 750

Yamamoto, 1996, Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome, J Clin Invest, 98, 30, 10.1172/JCI118773

Candeliere, 1995, Increased expression of the c-fos proto-oncogene in bone marrow from patients with fibrous dysplasia, N Engl J Med, 352, 1546, 10.1056/NEJM199506083322304

Kaplan, 1988, Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome), N Engl J Med, 319, 421, 10.1056/NEJM198808183190707

Liens, 1994, Long-term effects of intravenous pamidronate in fibrous dysplasia of bone, Lancet, 343, 953, 10.1016/S0140-6736(94)90069-8